Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation
- PMID: 40878238
- DOI: 10.1039/d5ay90112j
Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation
Abstract
Correction for 'Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation' by Samar M. Mahgoub et al., Anal. Methods, 2025, 17, 6215-6230, https://doi.org/10.1039/D5AY00698H.
Erratum for
-
Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation.Anal Methods. 2025 Jul 31;17(30):6215-6230. doi: 10.1039/d5ay00698h. Anal Methods. 2025. PMID: 40697177
Publication types
LinkOut - more resources
Full Text Sources
